Predictors of response to upfront bortezomib, lenalidomide and dexamethasone (VRd) in multiple myeloma.

Keruakous, A; Day, S; Borogovac, A; Holter, JL; Asch, AS; Yuen, C

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索